In this issue:
DESKTOP III: Secondary debulking at first relapse prolongs survival
Trametinib new standard of care for recurrent LGSOC
Exercise and nutrition plan during chemotherapy beneficial
Opportunistic salpingectomy may reduce ovarian cancer risk
Addition of HIPEC to cytoreductive surgery beneficial only after chemotherapy
PARCER: Reduced late toxicity with adjuvant IG-IM radiotherapy
Fertility-sparing surgery for stage IC2/3 EOC does not reduce survival
Ovarian cancer recurrence detection may not require physical examination
No benefit to more than three adjuvant chemotherapy cycles
Please login below to download this issue (PDF)